Get started

Financials · HHS

Harte Hanks Inc. (HHS) financials

For the twelve months ended Jun 30, 2026, Harte Hanks Inc. reported $154.63M of revenue and -$5.71M of net income.

Revenue, TTM
$154.63M
Revenue growth, YoY
-11.6%
Net income, TTM
-$5.71M
Net margin
-3.7%
Free cash flow, TTM
-$1.53M
EPS, diluted, TTM
-$0.76
Cash
$5.18M
P/S
0.19
Market cap
$29.5M
Annual revenue$159.57M
FY2016FY2025
Annual net income-$811.0K
FY2016FY2025
Annual free cash flow-$4.49M
FY2016FY2025

HHS revenue and earnings growth

HHS revenueQ2 2026$37.98M

Quarter YoY
-1.7%
QoQ
+1.9%
FY YoY
-13.9%
5Y CAGR
-2.0%
10Y CAGR
-9.7%

HHS revenue was $37.98M in fiscal Q2 2026 (ended Jun 30, 2026), down 1.7% from a year earlier and up 1.9% from the prior quarter. For the full fiscal 2025 it was $159.57M, down 13.9% from fiscal 2024. Compound annual growth was -2.0% over 5 years and -9.7% over 10 years. It rose in 2 of the last 10 fiscal years.

HHS net incomeQ2 2026-$5.00M

HHS net income was -$5.00M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$335.0K a year earlier. For the full fiscal 2025 it was -$811.0K, compared with -$30.30M in fiscal 2024.

HHS EPSQ2 2026-$0.67

HHS diluted EPS was -$0.67 in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$0.05 a year earlier. For the full fiscal 2025 it was -$0.11, compared with -$4.15 in fiscal 2024.

HHS free cash flowQ2 2026-$2.11M

HHS free cash flow was -$2.11M in fiscal Q2 2026 (ended Jun 30, 2026), compared with -$5.07M a year earlier. For the full fiscal 2025 it was -$4.49M, compared with -$6.73M in fiscal 2024.

Export CSV

Income statement

Income statement
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue$159.57M$185.24M$191.49M$206.28M$194.60M$176.90M$217.58M$284.63M$383.91M$404.41M
Selling, general and admin$22.21M$22.78M$20.67M$21.89M$17.86M$21.52M$24.29M---
Operating income$386.0K$2.09M$3.36M$15.11M$7.64M-$10.58M-$21.61M-$26.03M-$40.87M-$53.84M
Pre-tax income-$1.01M-$37.93M-$1.92M$19.31M$16.26M-$18.31M-$24.51M-$562.0K-$51.75M-$69.15M
Income tax-$197.0K-$7.64M-$349.0K-$17.46M$1.29M-$16.61M$1.75M-$18.11M-$9.89M$20.63M
Net income-$811.0K-$30.30M-$1.57M$36.78M$14.97M-$1.69M-$26.26M$17.55M-$41.86M-$130.94M
EPS, basic-$0.11-$4.15-$0.21$4.98$1.85-$0.34-$4.26$2.39-$6.76-$21.29
EPS, diluted-$0.11-$4.15-$0.21$4.75$1.76-$0.34-$4.26$2.38-$6.76-$21.29
Diluted shares7.4M7.3M7.3M7.5M7.2M6.5M6.3M6.3M6.2M6.1M

Balance sheet

Balance sheet
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Cash and equivalents$5.59M$9.93M$18.86M$11.36M$15.13M$33.56M$34.12M$20.88M$8.40M$46.01M
Receivables$27.84M$31.65M$34.31M$39.70M$41.05M$36.02M$38.97M$54.24M$81.40M$88.81M
Inventory-----$46.0K$354.0K$448.0K$587.0K$838.0K
Current assets$46.32M$53.61M$65.21M$66.31M$75.38M$86.24M$79.30M$104.99M$103.21M$149.43M
Goodwill$295.0K$295.0K$1.93M$2.40M$0--$0$0$34.51M
Total assets$91.83M$101.78M$122.76M$119.98M$107.86M$119.50M$110.20M$125.17M$130.81M$213.44M
Current liabilities$30.16M$35.14M$48.11M$43.57M$42.44M$47.19M$45.53M$54.16M$67.25M$104.67M
Short-term debt$0---$0$4.93M---$0
Long-term debt---$0$5.00M$22.17M$18.70M$14.20M$0$0
Total debt---$0$5.00M$27.10M$18.70M$14.20M$0$0
Total liabilities$71.30M$80.09M$102.90M$101.18M$122.85M$162.90M$150.16M$134.64M$165.45M$210.78M
Shareholders' equity$20.53M$21.69M$19.86M$18.81M-$24.71M-$53.12M-$49.68M-$19.18M-$34.63M$2.66M

Cash flow

Cash flow
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Operating cash flow-$1.74M-$2.99M$10.48M$28.79M-$1.76M-$7.84M$12.10M-$9.18M-$30.80M$14.59M
Capital expenditures$2.76M$3.75M$2.81M$5.80M$3.05M$2.70M$2.90M$4.21M$5.68M$6.69M
Free cash flow-$4.49M-$6.73M$7.67M$22.99M-$4.81M-$10.54M$9.20M-$13.39M-$36.48M$7.90M
Investing cash flow-$2.76M-$3.74M-$2.31M-$11.49M-$2.90M-$775.0K-$2.60M-$52.0K-$5.67M$99.70M
Financing cash flow$514.0K-$419.0K-$3.22M-$15.82M-$13.41M$7.31M$3.09M$22.73M-$1.46M-$85.30M
Dividends paid--------$0$5.29M
Share repurchases-$0$2.37M$0----$0$0
Stock-based compensation$258.0K$1.93M$1.42M$2.35M$1.47M$764.0K$1.07M-$581.0K$2.66M$2.67M
Depreciation and amortization$4.47M$4.38M$4.24M$2.73M$2.56M$3.62M$5.34M$7.45M$10.51M$12.35M

Key ratios

Key ratios
Line item
FY2025
Dec 31, 2025
FY2024
Dec 31, 2024
FY2023
Dec 31, 2023
FY2022
Dec 31, 2022
FY2021
Dec 31, 2021
FY2020
Dec 31, 2020
FY2019
Dec 31, 2019
FY2018
Dec 31, 2018
FY2017
Dec 31, 2017
FY2016
Dec 31, 2016
Revenue growth, YoY-13.9%-3.3%-7.2%6.0%10.0%-18.7%-23.6%-25.9%-5.1%-9.0%
Net income growth, YoY---145.6%------
EPS growth, YoY---169.9%------
Operating margin0.2%1.1%1.8%7.3%3.9%-6.0%-9.9%-9.1%-10.6%-13.3%
Net margin-0.5%-16.4%-0.8%17.8%7.7%-1.0%-12.1%6.2%-10.9%-32.4%
Free cash flow margin-2.8%-3.6%4.0%11.1%-2.5%-6.0%4.2%-4.7%-9.5%2.0%
Return on equity-4.0%-139.7%-7.9%195.5%------4929.9%
Return on assets-0.9%-29.8%-1.3%30.7%13.9%-1.4%-23.8%14.0%-32.0%-61.3%
Current ratio1.541.531.361.521.781.831.741.941.531.43
Debt to equity---0.00-----0.00

Source: XBRL data Harte Hanks Inc. files with the SEC, latest filing dated Aug 14, 2026 (see filings on SEC EDGAR). Provided for information only, not investment advice. Check the filing before relying on a number.

* Worked out from the filings rather than stated in them: Q4 is the full year less the first nine months.

Per-share figures and share counts are restated for stock splits the filings show: 1-for-10, first reported Mar 15, 2018.

EPS growth is left out where the share count moved enough to suggest a split the filings do not show. Growth rates need a positive starting figure. CAGR is compound annual growth between fiscal years. The CSV holds every period on file, in full figures, from the same SEC filings.

HHS peers

CompanyRevenueGrowthNet incomeNet marginMarket cap
HHS$154.63M-11.6%-$5.71M-3.7%$29.5M
OMC$24.76B+54.1%$704.90M2.8%$23.57B
WPP£13.55B-8.1%-£215.00M-1.6%$5.88B
STGW$3.11B+7.7%$9.69M0.3%$2.89B
IBTA$357.74M+1.6%-$16.06M-4.5%$1.36B
CRTO$1.81B-7.5%$77.95M4.3%$758.9M
GRPN$497.41M+2.0%-$125.66M-25.3%$629.7M
MNTN$313.33M+20.6%$56.40M18.0%$398.7M
ANGI$968.94M-8.4%-$231.08M-23.8%$283.5M

HHS FAQ

8 questions
  • What is HHS revenue?
    Harte Hanks Inc. (HHS) reported $154.63M of revenue for the twelve months ended Jun 30, 2026. That is down 11.6% from the year before. Revenue for fiscal 2025 was $159.57M.
  • Is HHS profitable?
    No. Harte Hanks Inc. reported a net loss of $5.71M for the twelve months ended Jun 30, 2026.
  • How much cash and debt does HHS have?
    Harte Hanks Inc. reported $5.18M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • How fast is HHS revenue growing?
    Harte Hanks Inc.'s revenue changed -13.9% in fiscal 2025, to $159.57M. Its compound annual growth rate was -2.0% over 5 years and -9.7% over 10 years.
  • What is HHS free cash flow?
    Harte Hanks Inc. generated -$1.53M of free cash flow for the twelve months ended Jun 30, 2026, which is operating cash flow of $1.29M less capital expenditures.
  • What is HHS earnings per share?
    Diluted earnings per share were -$0.76 for the twelve months ended Jun 30, 2026, from SEC filings, restated for any stock split those filings show.
  • When did HHS last report financial results?
    The latest statements here come from Harte Hanks Inc.'s 10-Q filed on Aug 14, 2026, covering the period ended Jun 30, 2026.
  • Where does this HHS financial data come from?
    Quantisnow builds these statements from the structured XBRL data Harte Hanks Inc. files with the SEC. It is provided for information only and is not investment advice.